Weight reduction in overweight or obese patients |
An initial aim of 10% body weight reduction should be included in a first-line approach for obese patients with OA. Overall aim for obese/overweight patients is for BMI within the healthy range (18.5–25 kg/m2)
Dietary modification should include moderate energy restriction without compromising micronutrient intake
Exercise should be encouraged including aspects of aerobic exercise, strengthening and flexibility that should be tailored to mobility
|
Regular clinical contact and monitoring, including dietetic input, are essential for dietary modification. Clinical input should incorporate a focus on behaviour change |
Beneficial dietary-lipid modification in OA patients |
Reduce intake of n-6 fatty acids by substituting oils rich in mono-unsaturates such as rapeseed, canola and olive oils.
Aim to increase intake of long-chain n-3 fatty acids via a direct source of EPA/DHA; increase intake of oily fish; aim to consume a minimum one portion per week (as in general healthy eating guidelines) and preferably two
Consider a daily standard fish oil supplement (1–2 capsules/day)
|
Women who are pregnant or breastfeeding should avoid fish with high levels of mercury (i.e. shark, swordfish and king mackerel) [46] and should avoid cod-liver oil due to the vitamin A content [47] |
Dietary management of cholesterol, serum lipids and comorbidities, CVD and MetS |
A cholesterol-lowering dietary portfolio should be advocated to patients with raised serum cholesterol (>5 mmol/l/>200 mg/dl) or LDL-C (>3 mmol/l/>100 mg/dl)a to reduce CHD risk with the potential for OA benefit
≥2 g/day plant stanols/sterols [49]
Reduce SFA intake to < 11% total energy (around 31 g/day for males and 24 g/day for females)
Ensure daily intake of viscous fibre (e.g. oats), soy protein (25 g) and nuts (30 g)
For obese/overweight patients, weight reductionb remains of primary importance both for OA symptom management and reduction in risk of the co-morbidities, CVD and MetS
|
|
To achieve adequate levels of vitamins A, C and E |
Ensure adequate daily intake through consumption of rich dietary sources (see supplementary Table S2, available at Rheumatology online)
Adult recommended intakes are shown below:
Vitamin A (retinol equivalent): 650–750 µg/day (Europe [50]); 700–900 µg/day (USA [51])c
Vitamin C: 95–110 mg/day (Europe [52]); 75–90 mg (USA [51])c
Vitamin E (α-tocopherol equivalent): an adequate intake level of 11–13 mg/day (Europe [53]); 15 mg/day (USA [51, 107])
Only consider a multivitamin supplement if dietary intake of these nutrients is insufficient to meet dietary recommendations. Obtaining intake through diet is preferable
|
US guidelines suggest an additional 30 mg/day Vitamin C for smokers |
To increase vitamin D intake/status |
Increase consumption of vitamin-D-rich foods, for example, oily fish, eggs (yolks), vitamin-D-fortified spreads, fortified milk, fortified cereals (see supplementary Table S2, available at Rheumatology online)
During the summer months, daily sunlight exposure (without protective cream/lotion) of approximately 10–20 min (depending on skin type, time of day, altitude and latitude) should be sufficient to produce adequate vitamin D [54, 55]
With minimal sun exposure, supplementation of 15–20 µg/day should be encouraged, based on European and American guidelines, to ensure sufficient vitamin D concentration [54, 55]
Maintaining a healthy BMI, that is, between 18.5 and 25 kg/m2, will reduce the risk of vitamin D sequestration in adipose tissue [54, 55, 126, 127]
|
|
To increase vitamin K intake |
Increase green-vegetable consumption, particularly of rich sources such as spinach, Brussels sprouts, kale and broccoli [56] (see supplementary Table S2, available at Rheumatology online for list of sources)
Certain fats and oils (e.g. blended vegetable oil, olive oil and margarine [56]) contain small amounts of vitamin K and therefore utilizing these in cooking or as plant spreads may increase intake
|
The addition of a fat (such as olive oil) to a vitamin K source may increase bioavailability, as vitamin K is fat-soluble |